Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease
NCT05572996 · Status: AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2022-10-10
Summary
This is an Expanded Access Program (EAP) for eligible participants with Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) designed to provide access to Inhaled Treprostinil. Availability will depend on territory elegibility.
Conditions
- Pulmonary Hypertension
- Interstitial Lung Disease
- Combined Pulmonary Fibrosis and Emphysema
Interventions
- DRUG
-
Inhaled Treprostinil
Sponsors & Collaborators
-
Ferrer Internacional S.A.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis
NCT05356052 ·Status: AVAILABLE
-
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
NCT03496623 ·Status: TERMINATED ·Phase: PHASE3
-
Inhaled Treprostinil for PAH: Open-label Extension
NCT01557660 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
NCT01557647 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
NCT03012646 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
NCT07333183 ·Status: RECRUITING ·Phase: PHASE2
-
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT07234032 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD
NCT05867914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT03794583 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT07179380 ·Status: RECRUITING ·Phase: PHASE3
-
An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT06939647 ·Status: AVAILABLE
-
A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
NCT05176951 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
NCT05747508 ·Status: UNKNOWN ·Phase: PHASE2
-
Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil
NCT03992755 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
NCT00703339 ·Status: TERMINATED ·Phase: PHASE2
-
Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen
NCT03135860 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
NCT02603068 ·Status: WITHDRAWN ·Phase: PHASE2
-
3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF
NCT02267655 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD
NCT04691154 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
NCT01494896 ·Status: TERMINATED
-
Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension
NCT07116681 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)
NCT07263958 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
NCT00439543 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective Study
NCT06605326 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
NCT00709098 ·Status: COMPLETED ·Phase: PHASE3